Is ERYP or XYLD a better dividend investment in 2026?

ERYP currently yields 256.41% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: ERYP offers higher current income.

What is the dividend yield difference between ERYP and XYLD?

ERYP has a forward dividend yield of 256.41% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 245.43 percentage points.

Home › Compare › ERYP vs XYLD

ERYP vs XYLD: Dividend Comparison 2026

ERYP yields 256.41% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ERYP wins by $541.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ERYP

● Live price

256.41%

Share price

$0.78

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$541.22M

Annual income

$306,262,465.48

Full ERYP calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — ERYP vs XYLD

📍 ERYP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ERYP	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ERYP + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ERYP pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERYP

Annual income on $10K today (after 15% tax)

$21,794.87/yr

After 10yr DRIP, annual income (after tax)

$260,323,095.66/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, ERYP beats the other by $260,320,359.49/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERYP + XYLD for your $10,000?

ERYP: 50%XYLD: 50%

100% XYLD50/50100% ERYP

Portfolio after 10yr

$270.62M

Annual income

$153,132,842.25/yr

Blended yield

56.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ERYP right now

ERYP

Analyst Ratings

Buy

Consensus: Buy

Altman Z

1.9

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERYP buys

XYLD buys

No recent congressional trades found for ERYP or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricERYPXYLD

Forward yield	256.41% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$541.22M ✓	$25.3K
Annual income after 10y	$306,262,465.48 ✓	$3,219.02
Total dividends collected	$516.37M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ERYP vs XYLD ($10,000, DRIP)

Year	ERYP Portfolio	ERYP Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$36,341	$25,641.03	$10,818	$1,098.39	+$25.5K → ERYP
2	$125,971	$87,086.09	$11,738	$1,222.51	+$114.2K → ERYP
3	$416,912	$282,122.92	$12,774	$1,364.64	+$404.1K → ERYP
4	$1,318,722	$872,626.36	$13,944	$1,527.86	+$1.30M → ERYP
5	$3,990,640	$2,579,607.07	$15,270	$1,715.87	+$3.98M → ERYP
6	$11,565,551	$7,295,566.53	$16,775	$1,933.09	+$11.55M → ERYP
7	$32,135,691	$19,760,551.21	$18,490	$2,184.87	+$32.12M → ERYP
8	$85,699,274	$51,314,084.97	$20,450	$2,477.63	+$85.68M → ERYP
9	$219,589,910	$127,891,686.63	$22,697	$2,819.19	+$219.57M → ERYP
10	$541,223,669	$306,262,465.48	$25,280	$3,219.02	+$541.20M → ERYP

ERYP vs XYLD: Complete Analysis 2026

ERYP — Stock

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

Full ERYP Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ERYP vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERYP vs SCHD ERYP vs JEPI ERYP vs O ERYP vs KO ERYP vs MAIN ERYP vs QYLD ERYP vs JEPQ ERYP vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.